Vinati Organics Ltd Q1 FY27 Earnings Analysis

- Expecting approximately 15% volume growth at the company level in FY 2027. - Antioxidants segment delivered 15% revenue growth in FY 2026, with strong momentum expected to continue in FY 2027 due to market expansion and product development. - Butyl phenols segment anticipates moderate growth in FY 2027 supported by improving demand. - IB and HP-MTBE products expected to achieve double-digit growth in FY 2027. - IBB volume declined in FY 2026 but production and sales are back on track. - Targeting around 15% to 20% volume growth in ATBS for FY 2027. - Strong pipeline of new niche chemical products targeting fragrance, personal care, food additives, plastics. - Around INR 200-250 crore capex planned for FY 2027 to support capacity expansion and innovation. - VOPL subsidiary expected to contribute INR 100-120 crores in revenue from Q3 FY27 after process reengineering.

- FY26 saw steady growth; FY27 volume growth expected around 15% across the company. - Antioxidants business grew 15% in FY26; expected to maintain strong momentum in FY27. - Butyl phenols segment to see moderate growth in FY27 with improving demand. - IB and HP-MTBE products forecasted for double-digit growth in FY27. - IBB volumes down 20% in FY26 due to raw material issues but now back on track; growth expected. - EBITDA margins targeted at a sustainable 26%-27% long-term. - Capex of INR 200-250 crores planned for FY27 aimed at capacity expansion, innovation, operational efficiency. - Revenue contribution from VOPL subsidiary expected from Q3 FY27 post reengineering. - Management aims to fund growth via internal accruals, maintaining debt-free status. - Overall, company targets approximately 15% volume growth year-on-year over the next 3 years.

- FY26 capex: Approximately INR 270 crores spent, including capacity expansion, new product development, and operational scalability. - ATBS capacity expansion completed, significantly enhancing production capability. - FY27 capex guidance: INR 200 to 250 crores planned for capacity expansion, innovation, and operational efficiency. - Projected capex split for FY27: Around INR 40-50 crores for VOPL subsidiary; INR 200 crores for the main holding company. - Focus on organic growth with investments in downstream, value-added, and niche chemicals targeting industries like food additives, fragrance, plastics, and personal care. - Process reengineering ongoing at VOPL, expected completion by September, with revenue from Q3 FY27. - New products under commissioning and R&D phase with revenues expected starting FY28. - Expansion plans funded through internal accruals; company remains debt-free with a treasury balance of about INR 190 crores as of March 31, 2026.

- Vinati Organics Limited has not indicated any plans for fundraising through debt or equity. - The company has maintained a policy of growth through internal accruals and remains debt-free. - Current and upcoming expansions and capital expenditure (capex) plans are being funded internally. - As of March 31, 2026, the company holds a treasury of approximately INR190 crores. - Management reiterated no plans for aggressive inorganic expansion or taking on debt in the near future. - Planned organic expansions include capex of around INR250-300 crores annually over the next 3 to 5 years, funded internally.

- No specific mention of a current or expected order book or pending orders was provided in the transcript. - Regarding ATBS, the company is running at about 75%-80% capacity utilization post-expansion, indicating steady demand. - There is no direct mention of a backlog of orders for ATBS or other products. - Discussions highlighted cyclical demand fluctuations and channel destocking but no explicit order backlog details. - The management is confident about approximately 15% volume growth in FY27 and beyond for ATBS and other segments. - Revenue contributions from new capacity expansions and product pipelines (including the subsidiary VOPL) are anticipated starting Q3 FY27. - The focus remains on organic growth with planned capex around INR250-300 crores per year for the next 3-5 years to support expansion and new product commissioning.